These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8843233)

  • 1. An estimate of the number of human immunodeficiency virus (HIV)-positive blood donations by HIV-seronegative donors in a northern Thailand HIV epicenter.
    Sawanpanyalert P; Yanai H; Kitsuwannakul S; Nelson KE
    J Infect Dis; 1996 Oct; 174(4):870-3. PubMed ID: 8843233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group.
    Petersen LR; Satten GA; Dodd R; Busch M; Kleinman S; Grindon A; Lenes B
    Transfusion; 1994 Apr; 34(4):283-9. PubMed ID: 8178324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related risk factors of blood donors in northern Thailand before and after knowing HIV test results.
    Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
    Int J Epidemiol; 1997 Apr; 26(2):408-13. PubMed ID: 9169178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood safety: improvements needed in Thailand.
    AIDS Wkly Plus; 1996 Oct 7-14; ():16. PubMed ID: 12291667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of HIV infection by seronegative blood in Thailand.
    Isarangkura P; Chiewsilp P; Tanprasert S; Nuchprayoon C
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():106-13. PubMed ID: 7822978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predonation screening of candidate donors and prevention of window period donations.
    Lieshout-Krikke RW; Zaaijer HL; van de Laar TJ
    Transfusion; 2015 Feb; 55(2):373-8. PubMed ID: 25130605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.
    Minga A; Dohoun L; Abo Y; Coulibaly A; Konaté S; Ouattara HP; N'guessan BK; Dabis F; Salamon R; Lewden C;
    Transfusion; 2010 Apr; 50(4):888-93. PubMed ID: 19951316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
    Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher risk, test-seeking donors attracted to blood centers? Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Busch MP; Williams AE
    Transfusion; 1996 Mar; 36(3):203-8. PubMed ID: 8604502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
    Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL
    Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting seronegative-early HIV infections among adult versus student Kenyan blood donors, by using Stimmunology.
    Mumo J; Vansover A; Jehuda-Cohen T
    Exp Biol Med (Maywood); 2009 Aug; 234(8):931-9. PubMed ID: 19491368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV transmission by seronegative blood components: report of 2 probable cases.
    Isarangkura P; Mahaphan W; Chiewsilp P; Chuansumrit A; Hathirat P
    Vox Sang; 1993; 65(2):114-6. PubMed ID: 8212665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.